Halma PLC banner

Halma PLC
LSE:HLMA

Watchlist Manager
Halma PLC Logo
Halma PLC
LSE:HLMA
Watchlist
Price: 3 756 GBX -2.74%
Market Cap: £14.3B

Halma PLC
Investor Relations

Halma PLC is a remarkable story of strategic evolution and steady perseverance in the world of niche market technologies. Founded in 1894 and initially involved in the rubber processing industry, the company transformed into a globally recognized enterprise dedicated to creating a safer, cleaner, and healthier environment. Headquartered in Amersham, UK, Halma operates through a decentralized model, comprising around 50 small businesses organized under four sectors: Process Safety, Infrastructure Safety, Environmental & Analysis, and Medical. This structure enables Halma to remain agile, fostering innovation and responsiveness to market changes. By acquiring companies that align with its mission and prioritizing continuous R&D investment, Halma fortifies its position as a leader in its chosen sectors.

Revenue generation for Halma is predominantly driven by the sale of products and services that ensure safety and compliance across various industries. Within its Process Safety division, Halma supplies devices aimed at protecting industrial plants from explosion hazards, while its Infrastructure Safety segment focuses on sensor technologies to mitigate risks in work environments. The group’s Environmental & Analysis arm offers sophisticated systems for water quality monitoring and pollution control, reflecting industry needs for environmental stewardship. Meanwhile, its Medical segment provides products aiding in patient assessment and treatment, ranging from ophthalmic instruments to diagnostic solutions. This diversified business model, emphasizing necessity-driven technologies, ensures Halma a stable income stream and positions it as a resilient enterprise capable of adapting to global challenges.

Show more
Loading
HLMA
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Nov 20, 2025
AI Summary
Q2 2026

Record Results: Halma delivered record half-year results, with strong organic growth and margin expansion across all three sectors.

Revenue & Profit Growth: Revenue grew 15% (14% excluding a one-off), while EBIT increased 27% (23% excluding a one-off), both well ahead of previous periods.

Margin Expansion: First-half EBIT margin rose to 22.3%, up 160 basis points, with all sectors contributing to margin improvement.

Upgraded Guidance: Management upgraded full-year guidance for the second time, now expecting mid-teens organic constant currency revenue growth and an adjusted EBIT margin of around 22%.

Strong Returns & Dividend: Return on capital increased to 16.2%, and Halma is on track for its 47th consecutive year of dividend increases of 5% or more.

Continued Investment: The group invested over GBP 300 million in R&D, acquisitions, CapEx, and working capital to support future growth.

Photonics Outperformance: The Photonics business continues to deliver premium growth, driven by demand from a long-term hyperscaler customer.

Sustained Organic Growth: Strong organic growth was broad-based, with Environmental & Analysis sector organic revenue up 36% and Safety sector profit margin reaching a historic high.

Key Financials
EBIT Margin
22.3%
Return on Capital
16.2%
Cash Conversion
79%
Net Debt to EBITDA
Just over 1x
R&D Spend
GBP 60 million
Total Investment
Over GBP 300 million
Acquisitions Spend
GBP 130 million
CapEx and Working Capital
Over GBP 100 million
Dividend Growth
47th year of dividend increases of 5% or more (on track)
Safety Sector Organic Revenue Growth
6%
Safety Sector Profit Growth
16%
Safety Sector Margin
27%
Safety Sector R&D Spend
6.1% of revenue
Environmental & Analysis Organic Revenue Growth
36%
Environmental & Analysis Organic Profit Growth
38%
Environmental & Analysis Margin
23.6%
Environmental & Analysis Acquisitions Contribution
4.3%
Healthcare Sector Profit Growth
10%
Healthcare Sector Margin
21.3%
Healthcare Sector R&D Spend
5.4% of sales
Earnings Call Recording
Other Earnings Calls
2026
2022

Management

Mr. Stephen William Lawrence Gunning
CFO, Member of Executive Board & Director
No Bio Available
Ms. Jennifer Suzanne Ward
Group Talent, Culture & Communications Director, Member of Executive Board and Executive Director
No Bio Available
Mr. Marc Arthur Ronchetti
Group CEO, Member of Executive Board & Executive Director
No Bio Available
Ms. Catherine E. Michel
CTO & Member of Executive Board
No Bio Available
Ms. Funmi Adegoke
CEO of Safety Sector & Member of Executive Board
No Bio Available
Ms. Constance F. Baroudel
Chief Sustainability Officer, Sector CEO of Env. & Analysis and Member of Executive Board
No Bio Available
Mr. Steve Brown
Sector Chief Executive of Healthcare & Member of Executive Board
No Bio Available
Mr. Aldous Wong
President of Halma Asia Pacific, Adviser & Member of Executive Board
No Bio Available
Mr. Charles King
Head of Investor Relations
No Bio Available
Ms. Charlene Lim
Group General Counsel
No Bio Available

Contacts

Address
BUCKINGHAMSHIRE
Amersham
Misbourne Court, Rectory Way
Contacts
+441494721111.0
www.halma.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett